5,500,000 Shares ISTA PHARMACEUTICALS, INC. COMMON STOCK UNDERWRITING AGREEMENT Dated January 20, 2005Underwriting Agreement • January 21st, 2005 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJanuary 21st, 2005 Company Industry JurisdictionIntroduction. ISTA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”) 5,500,000 shares of the Common Stock, par value $0.001 per share, of the Company (the “Firm Shares”).